
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Gelsolin CRISPR/Cas9 KO Plasmid (m) | sc-432743 | 20 µg | $397.00 |
Mouse Gsn encodes gelsolin, a Ca2+-regulated actin-binding protein that severs, caps, and nucleates actin filaments to control cytoskeletal remodeling. By tuning actin dynamics, gelsolin contributes to cell shape changes, motility, endocytosis, and phagocytosis, and it interfaces with signaling networks such as phosphoinositide regulation and Rho family GTPase–linked pathways that couple membrane cues to actin reorganization. Altered gelsolin activity and expression have been associated with dysregulated cell migration, inflammatory responses, and tissue remodeling, making it a useful node for studying cytoskeleton-driven phenotypes. In mouse systems, Gsn perturbation supports mechanistic research on actin-dependent processes relevant to vascular biology, neurobiology, and immune cell function.
Gelsolin CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Gsn gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Gsn together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Gsn open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Gelsolin protein expression.
This CRISPR knockout system enables efficient generation of Gsn-deficient cell models for investigation of Gelsolin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.